News Sentiment

FEMY sentiment intelligence

Femasys Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 43 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 3.99 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 43

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-4.3% over one week, -4.5% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

FEMY - Femasys Inc Earnings

Market Reaction

Price moving ahead of tone

65/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction -4.3% Price reacting lower
Trend fit Trend inactive -4.5% over four weeks
Fair value -78.8% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 23
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 43
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 11
The Globe and Mail 5
GlobeNewswire 5
TradingView 4
TradingKey 4
Finviz 3
Moomoo 2
Minichart 1

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 5
Regulatory and legal 4
Deals and strategy 2
Guidance 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 43
Finviz Direct company coverage

FEMY - Femasys Inc Earnings

This page provides a detailed financial overview of Femasys Inc. (FEMY), including its last closing price, key financial metrics like market cap, income, and sales, and various performance indicators. It covers essential data such as EPS, sales growth, insider/institutional owner

Tone
Negative 39/100
Event
Earnings
Published
02 Jul 2026 14:41
Source
Finviz
Finviz Direct company coverage

FEMY - Femasys Inc Options

This article provides a comprehensive overview of Femasys Inc (FEMY) stock options and key financial metrics. It details the company's last close price, dollar and percentage changes, market capitalization, enterprise value, and various financial ratios. The report also includes

Tone
Negative 31/100
Event
Market update
Published
02 Jul 2026 14:41
Source
Finviz
The Globe and Mail Direct company coverage

Femasys Regains Nasdaq Compliance After Reverse Stock Split

Femasys Inc. (FEMY) has successfully regained compliance with Nasdaq's minimum bid price requirement following a 1-for-20 reverse stock split executed on June 5, 2026. This move resolves a delisting risk, allowing the company to concentrate on commercializing its reproductive hea

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 16:12
Source
The Globe and Mail
Stock Titan Direct company coverage

Femasys (FEMY) investors back directors and KPMG auditor at 2026 meeting

Femasys Inc. held its Annual Meeting of Stockholders where shareholders elected two Class II directors, Charles Larsen and Kenneth Eichenbaum, for three-year terms. They also ratified the appointment of KPMG LLP as the independent registered accounting firm for the fiscal year en

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 20:09
Source
Stock Titan
Minichart Direct company coverage

Femasys Regains Nasdaq Compliance and Expands Global Access to Innovative Fertility and Birth Control Solutions

Femasys Inc. (NASDAQ: FEMY) has regained compliance with Nasdaq's minimum bid price requirement, removing a significant overhang on its stock. The company is focused on advancing its fertility and non-surgical birth control solutions, including FemaSeed for infertility and FemBlo

Tone
Positive 73/100
Event
Market update
Published
24 Jun 2026 15:11
Source
Minichart
Moomoo Direct company coverage

Femasys Regains Compliance With Nasdaq Minimum Bid Price Rule

Femasys Inc. announced it has regained compliance with Nasdaq's minimum bid price rule. This means the company's common stock has achieved a closing bid price of at least $1.00 for ten consecutive business days, satisfying Listing Rule 5550(a)(2). As a result, the previously anno

Tone
Positive 70/100
Event
Market update
Published
24 Jun 2026 15:09
Source
Moomoo
TradingView Direct company coverage

Femasys regains Nasdaq minimum bid compliance after 1-for-20 reverse split

Femasys (FEMY) has successfully regained compliance with Nasdaq's $1.00 minimum bid requirement. This achievement follows a 1-for-20 reverse stock split that became effective on June 5, 2026, with the company's closing bid price remaining above $1.00 for 10 consecutive business d

Tone
Positive 68/100
Event
Market update
Published
24 Jun 2026 14:09
Source
TradingView
GlobeNewswire Direct company coverage

Femasys Regains Compliance with Nasdaq Listing Requirements

Femasys Inc. announced it has regained compliance with Nasdaq's minimum bid price requirement for continued listing, with the matter now officially closed. CEO Kathy Lee-Sepsick stated that this development is important for the company and its shareholders, allowing Femasys to fo

Tone
Positive 75/100
Event
Market update
Published
24 Jun 2026 13:09
Source
GlobeNewswire
Stock Titan Direct company coverage

Femasys (NASDAQ: FEMY) back in compliance with Nasdaq listing requirements

Femasys Inc. (NASDAQ: FEMY) has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share, following a 1-for-20 reverse stock split that became effective on June 5, 2026. The company's closing bid price remained at or above $1.00 for ten consecutive busin

Tone
Positive 70/100
Event
Market update
Published
24 Jun 2026 13:09
Source
Stock Titan
TradingKey Direct company coverage

Femasys Inc (FEMY) Financial Health: Profitability & Balance Sheet Analysis

Femasys Inc (FEMY) has a current financial score of 4.73, ranking 201 out of 204 in the Healthcare Equipment & Supplies industry. The company's financial status is stable with low operating efficiency, despite a recent 24.50% year-over-year revenue increase and a 114.35% year-ove

Tone
Positive 62/100
Event
Earnings
Published
18 Jun 2026 05:38
Source
TradingKey
TradingKey Direct company coverage

Femasys Inc (FEMY) Institutional Confidence

This article from TradingKey focuses on the institutional confidence in Femasys Inc (FEMY). It details the institutional shareholding, including the top shareholders and the changes in their held shares, indicating a mix of increased and decreased positions among major investors.

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 05:38
Source
TradingKey
TradingKey Direct company coverage

Femasys Inc (FEMY) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Femasys Inc (FEMY) stock, focusing on its dividend and stock split history. It notes that Femasys Inc has not distributed any dividends over the past five years and details one upcoming merger-related stock split scheduled for June 4, 2026. Th

Tone
Neutral 50/100
Event
Deals and strategy
Published
17 Jun 2026 17:10
Source
TradingKey
TradingKey Direct company coverage

Femasys Inc (FEMY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Femasys Inc (FEMY). It lists financial periods for which revenue data is typically disclosed, noting that relevant data has not yet been provided by the company for specific segments. The only disclosed regional revenue shows the Unit

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 17:10
Source
TradingKey
The Globe and Mail Direct company coverage

Femasys Announces 1-for-20 Reverse Stock Split Implementation

Femasys Inc. (FEMY) has implemented a 1-for-20 reverse stock split on June 5, 2026, following stockholder authorization. This action aims to help the company maintain Nasdaq listing compliance and potentially improve its per-share trading price. The stock is scheduled to trade on

Tone
Negative 36/100
Event
Market update
Published
10 Jun 2026 21:09
Source
The Globe and Mail
Stock Titan Direct company coverage

Femasys (NASDAQ: FEMY) implements 1-for-20 reverse stock split

Femasys Inc. (NASDAQ: FEMY) has completed a 1-for-20 reverse stock split, effective 8:40 a.m. Eastern Time on June 5, 2026. This action consolidates every 20 outstanding shares into one, with no change to the $0.001 par value, and proportionately adjusts all stock options, RSUs,

Tone
Neutral 50/100
Event
Market update
Published
05 Jun 2026 20:09
Source
Stock Titan
TradingView Direct company coverage

Femasys to implement 1-for-20 reverse stock split; trading symbol FEMY unchanged

Femasys (FEMY) announced a 1-for-20 reverse stock split of its common stock, effective June 5, 2026, at 4:30 p.m. ET. Shares will trade on a split-adjusted basis from market open on June 8, with the trading symbol remaining FEMY and a new CUSIP. Each 20 pre-split shares will conv

Tone
Neutral 50/100
Event
Market update
Published
04 Jun 2026 12:40
Source
TradingView
Stock Titan Direct company coverage

Reverse split will consolidate Femasys (NASDAQ: FEMY) common shares 20-to-1

Femasys Inc. (NASDAQ: FEMY) announced a 1-for-20 reverse stock split of its common shares, effective at 4:30 p.m. Eastern Time on June 5, 2026. Each 20 pre-split shares will convert into one post-split share, with fractional shares rounded up to the nearest whole share. Split-adj

Tone
Negative 35/100
Event
Market update
Published
04 Jun 2026 12:40
Source
Stock Titan
TradingView Direct company coverage

Femasys, Inc. Financial Disclosures & SEC Filings

This page provides access to Femasys Inc.'s financial disclosures and SEC filings, including Forms 10-K, 10-Q, and 8-K. Users can explore various documents to evaluate the company's financial performance and operational updates. The listings include earnings reports and corporate

Tone
Positive 74/100
Event
Earnings
Published
03 Jun 2026 10:09
Source
TradingView
Finviz Direct company coverage

FEMY - Femasys Inc Stock Price and Quote

This article provides comprehensive financial data and recent news for Femasys Inc. (FEMY). It includes stock performance metrics, valuation ratios, insider and institutional ownership, and a detailed chronological list of company announcements and events, highlighting developmen

Tone
Positive 63/100
Event
Market update
Published
01 Jun 2026 12:12
Source
Finviz
Intellectia AI Direct company coverage

FEMY Technical Analysis & Stock Price Forecast

Femasys Inc (FEMY) currently has a "Strong Sell" technical sentiment, according to an analysis based on 9 technical signals where 7 indicate sell and 2 indicate buy as of May 29, 2026. The stock is trading below its 60-day ($0.44) and 200-day ($0.569) moving averages, with a curr

Tone
Negative 13/100
Event
Guidance
Published
01 Jun 2026 08:39
Source
Intellectia AI
Sahm Direct company coverage

Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter

Femasys Inc. announced CE Mark approval for its FemHSG™ Catheter, expanding its fertility care portfolio in Europe. This catheter, used with the FemVue® device, supports efficient in-office fertility evaluations. The approval aims to improve access to timely and affordable fertil

Tone
Positive 73/100
Event
Regulatory and legal
Published
14 May 2026 17:09
Source
Sahm
Investing.com UK Direct company coverage

Femasys receives CE Mark approval for FemHSG fertility catheter

Femasys Inc. has received CE Mark approval for its FemHSG Catheter, expanding its fertility product portfolio in Europe. This catheter, designed for in-office fertility evaluation, works with the FemVue device for uterine and fallopian tube assessment. Despite a recent stock decl

Tone
Positive 70/100
Event
Regulatory and legal
Published
14 May 2026 03:38
Source
Investing.com UK
Stock Titan Direct company coverage

Femasys (NASDAQ: FEMY) outlines FemaSeed fertility and FemBloc birth control strategy

Femasys Inc. filed an 8-K to present an updated corporate presentation detailing its women's reproductive health portfolio and growth strategy. The presentation focuses on FemaSeed for in-office fertility treatment and FemBloc, a non-surgical permanent birth control undergoing a

Tone
Positive 71/100
Event
Market update
Published
14 May 2026 03:09
Source
Stock Titan
TipRanks Direct company coverage

Femasys updates corporate presentation on women’s health portfolio

Femasys (FEMY) has released an updated corporate slide presentation for investors, analysts, and other stakeholders. The presentation highlights the company's diverse women's health portfolio, which includes fertility solutions and non-surgical permanent birth control products, a

Tone
Neutral 50/100
Event
Market update
Published
13 May 2026 22:09
Source
TipRanks
TradingView Direct company coverage

Femasys posts updated corporate presentation detailing fertility and FemBloc commercialization plans

Femasys (FEMY) has released an updated corporate presentation outlining its commercial strategy, clinical progress, and near-term milestones for its fertility and non-surgical permanent birth control solutions. Key highlights include FemaSeed's clinical data showing a ~2x pregnan

Tone
Positive 76/100
Event
Market update
Published
13 May 2026 21:09
Source
TradingView
Stock Titan Direct company coverage

New in-office fertility catheter approved in Europe to support faster diagnosis

Femasys (NASDAQ: FEMY) has received CE Mark approval for its FemHSG Catheter, allowing it to expand its fertility care portfolio in Europe. This catheter, used with the FemVue device, enables streamlined, in-office ultrasound-based evaluation during initial fertility workups, mak

Tone
Positive 86/100
Event
Regulatory and legal
Published
13 May 2026 13:09
Source
Stock Titan
The Globe and Mail Direct company coverage

Femasys Reverse Stock Split May Not Prevent Nasdaq Delisting Risk, Observer Warns

An external observer warns that a reverse stock split by Femasys, Inc. (FEMY) to comply with Nasdaq's minimum bid price may not guarantee sustained compliance. The observer suggests that the post-split price increase might be temporary, and Femasys could still fail other Nasdaq c

Tone
Negative 29/100
Event
Market update
Published
11 May 2026 14:39
Source
The Globe and Mail